JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCMP
1626
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $17.6M | ﹤0.01% |
+981,726
| New | +$12.1M |
|
1627
Nuveen Floating Rate Income Fund
JFR
$1.26B
| $17.6M | ﹤0.01% |
1,566,000
| – | – |
|
|
JAG
1628
DELISTED
Jagged Peak Energy Inc.
JAG
| $17.6M | ﹤0.01% |
1,112,384
-68,189
| -6% | -$986K |
|
|
MDR
1629
DELISTED
McDermott International
MDR
| $17.5M | ﹤0.01% |
888,535
-12,250
| -1% | -$259K |
|
1630
A.O. Smith
AOS
$8.48B
| $17.4M | ﹤0.01% |
284,791
-64,440
| -18% | -$3.91M |
|
|
FNGN
1631
DELISTED
Financial Engines, Inc.
FNGN
| $17.4M | ﹤0.01% |
574,775
+12,955
| +2% | +$407K |
|
|
APC
1632
PUT
DELISTED
Anadarko Petroleum
APC
| $17.4M | ﹤0.01% |
324,400
+214,400
| +195% | +$10.5M |
|
1633
BlackRock Debt Strategies Fund
DSU
$601M
| $17.3M | ﹤0.01% |
1,480,259
+33,382
| +2% | +$390K |
|
|
HPP
1634
Hudson Pacific Properties
HPP
$740M
| $17.3M | ﹤0.01% |
72,173
+40,080
| +125% | +$9.63M |
|
1635
Methode Electronics
MEI
$581M
| $17.3M | ﹤0.01% |
431,448
+123,206
| +40% | +$5.49M |
|
1636
Pinnacle West Capital
PNW
$12B
| $17.3M | ﹤0.01% |
203,100
-113,670
| -36% | -$10M |
|
1637
F5
FFIV
$23.2B
| $17.3M | ﹤0.01% |
131,579
+9,654
| +8% | +$1.2M |
|
1638
U-Haul Holding Co
UHAL
$14.4B
| $17.3M | ﹤0.01% |
456,860
+253,320
| +124% | +$9.47M |
|
1639
iShares US Technology ETF
IYW
$25.3B
| $17.2M | ﹤0.01% |
423,840
-1,080
| -0.3% | -$43.3K |
|
1640
iShares Russell 2000 Growth ETF
IWO
$14.9B
| $17.2M | ﹤0.01% |
92,321
+63,819
| +224% | +$11.6M |
|
|
RDS.B
1641
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $17.2M | ﹤0.01% |
251,980
-14,157
| -5% | -$918K |
|
1642
Peabody Energy
BTU
$3B
| $17.1M | ﹤0.01% |
435,347
+127,110
| +41% | +$4.13M |
|
|
TSG
1643
DELISTED
The Stars Group Inc.
TSG
| $17.1M | ﹤0.01% |
735,022
+171,247
| +30% | +$3.73M |
|
1644
PUT
American Tower
AMT
$78.8B
| $17.1M | ﹤0.01% |
119,600
+25,600
| +27% | +$3.65M |
|
1645
Regis Corp
RGS
$70.8M
| $17.1M | ﹤0.01% |
55,524
-11,689
| -17% | -$3.59M |
|
|
SYKE
1646
DELISTED
SYKES Enterprises Inc
SYKE
| $17M | ﹤0.01% |
541,756
+48,833
| +10% | +$1.47M |
|
|
KEM
1647
DELISTED
KEMET Corporation
KEM
| $17M | ﹤0.01% |
1,129,678
+658,390
| +140% | +$12.5M |
|
1648
CALL
Eagle Materials
EXP
$6.47B
| $17M | ﹤0.01% |
+150,000
| New | +$16.2M |
|
|
DNB
1649
DELISTED
Dun & Bradstreet
DNB
| $17M | ﹤0.01% |
143,526
-27,854
| -16% | -$3.31M |
|
1650
Coherus Oncology
CHRS
$192M
| $16.9M | ﹤0.01% |
1,924,494
+173,292
| +10% | +$1.86M |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.